Page 53 - Demo

www.psypharma.ru %u0421%u043e%u0432%u0440%u0435%u043c%u0435%u043d%u043d%u0430%u044f %u0442%u0435%u0440%u0430 %u043f%u0438%u044f %u043f%u0441%u0438%u0445%u0438%u0447%u0435%u0441%u043a%u0438%u0445 %u0440%u0430 %u0441%u0441%u0442%u0440%u043e%u0439%u0441%u0442%u0432 %u2116 4/2024%u0421%u0435%u043b%u0438%u0432%u0430%u043d%u043e%u0432 %u0413.%u042e., %u0411%u043e%u0445%u0430%u043d %u041d.%u0410. %u0438 %u0434%u0440.53%u041d%u041e%u0412%u042b%u0415 %u041b%u0415%u041a%u0410%u0420%u0421%u0422%u0412%u0415%u041d%u041d%u042b%u0415 %u0421%u0420%u0415%u0414%u0421%u0422%u0412%u04109. Barab%u0430%ue088ssy %u0410%ue098., Dombi Z.B., Csehi R., Djuric D., N%u0435%ue088meth G. The Role of Partial Agonists and Specifically Cariprazine in Dual Disorders // European Psychiatry. %u2013 2024. %u2013 Vol. 67 (S1). %u2013 Pp. 215%u2013S215. %u2013 https://doi.org/10.1192/j.eurpsy.2024.4619. Barab%u0430%ue088ssy %u0410%ue098., Dombi Z.B., Csehi R., Djuric D., N%u0435%ue088meth G. The Role of Partial Agonists and Specifically Cariprazine in Dual Disorders // European Psychiatry. %u2013 2024. %u2013 Vol. 67 (S1). %u2013 Pp. 215%u2013S215. %u2013 https://doi.org/10.1192/j.eurpsy.2024.46110. Grunze H. The role of the D3 dopamine receptor and its partial agonist Cariprazine in patients with schizophrenia and substance use disorder // Expert Opinion on Pharmacotherapy. %u2013 2023. %u2013 Vol. 24 (18). %u2013 Pp. 1985%u20131992. %u2013 https://doi.org/10.1080/14656566.2023.226635910. Grunze H. The role of the D3 dopamine receptor and its partial agonist Cariprazine in patients with schizophrenia and substance use disorder // Expert Opinion on Pharmacotherapy. %u2013 2023. %u2013 Vol. 24 (18). %u2013 Pp. 1985%u20131992. %u2013 https://doi.org/10.1080/14656566.2023.226635911. Martinotti G., Chiappini S., Mosca A., Miuli A., Santovito M.C., Pettorruso M., Skryabin V., Sensi S.L., Giannantonio M.D. Atypical antipsychotic drugs in dual disorders: Current evidence for clinical practice // Current Pharmaceutical Design. %u2013 2022. %u2013 Vol. 28 (27). %u2013 Pp. 2241%u20132259. %u2013 https://doi.org/10.2174/138161282866622062309285311. Martinotti G., Chiappini S., Mosca A., Miuli A., Santovito M.C., Pettorruso M., Skryabin V., Sensi S.L., Giannantonio M.D. Atypical antipsychotic drugs in dual disorders: Current evidence for clinical practice // Current Pharmaceutical Design. %u2013 2022. %u2013 Vol. 28 (27). %u2013 Pp. 2241%u20132259. %u2013 https://doi.org/10.2174/138161282866622062309285312. Nestora S., Pablob V., Carlos R., Lolag P., Larai G.-L., Ignaciob B.-V. Cariprazine as a maintenance treatment in dual schizophrenia: a 6-month observational study in patients with schizophrenia and cannabis use disorder // International Clinical Psychopharmacology. %u2013 2024. %u2013 https://doi.org/10.1097/YIC.000000000000056812. Nestora S., Pablob V., Carlos R., Lolag P., Larai G.-L., Ignaciob B.-V. Cariprazine as a maintenance treatment in dual schizophrenia: a 6-month observational study in patients with schizophrenia and cannabis use disorder // International Clinical Psychopharmacology. %u2013 2024. %u2013 https://doi.org/10.1097/YIC.000000000000056813. %u041d%u0430%u0441%u044b%u0440%u043e%u0432%u0430 %u0420.%u0424., %u041d%u0435%u0437%u043d%u0430%u043d%u043e%u0432 %u041d.%u0413., %u0428%u043d%u0430%u0439%u0434%u0435%u0440 %u041d.%u0410., %u041f%u0435%u0442%u0440%u043e%u0432%u0430 %u041c.%u041c. %u041b%u0435%u043a%u0430%u0440%u0441%u0442%u0432%u0435%u043d%u043d%u043e-%u0438%u043d%u0434%u0443%u0446%u0438%u0440%u043e%u0432%u0430%u043d%u043d%u044b%u0439 %u0441%u0438%u043d%u0434%u0440%u043e%u043c %u0443%u0434%u043b%u0438%u043d%u0435%u043d%u043d%u043e%u0433%u043e %u0438%u043d%u0442%u0435%u0440%u0432%u0430%u043b%u0430 QT %u0432 %u043f%u0441%u0438%u0445%u0438%u0430%u0442%u0440%u0438%u0438 %u0438 %u043d%u0435%u0432%u0440%u043e%u043b%u043e%u0433%u0438%u0438. %u2013 %u0421%u041f%u0431.: %u0414%u0415%u0410%u041d,2024. %u2013 592 %u0441.13. Nasyrova R.F., Neznanov N.G., Shnajder N.A., Petrova M.M. Lekarstvenno-inducirovannyj sindrom udlinennogo intervala QT v psihiatrii i nevrologii. %u2013 SPb.: DEAN, 2024. %u2013 592 s.14. Montero-Hernandez G., Alberdi-P%u0430%ue088ramo I., P%u0435%ue088rez-Lombardo M., Rodr%u00edguez-Quijano J., Pem%u0430%ue088n-Rodr%u00edguez J., Ib%u0430%ue088%u00f1ez-Vizoso J.E. New drugs in the treatment of dual psychosis: Use of cariprazine in schizophrenia, other psychotic disorders and use of cocaine. A case series in a specific outpatient psychiatric clinic for substance use disorders // European Psychiatry. %u2013 2024. %u2013 Vol. 67 (S1). %u2013 Pp. 294-S295. %u2013 https://doi.org/10.1192/j.eurpsy.2024.61314. Montero-Hernandez G., Alberdi-P%u0430%ue088ramo I., P%u0435%ue088rez-Lombardo M., Rodr%u00edguez-Quijano J., Pem%u0430%ue088n-Rodr%u00edguez J., Ib%u0430%ue088%u00f1ez-Vizoso J.E. New drugs in the treatment of dual psychosis: Use of cariprazine in schizophrenia, other psychotic disorders and use of cocaine. A case series in a specific outpatient psychiatric clinic for substance use disorders // European Psychiatry. %u2013 2024. %u2013 Vol. 67 (S1). %u2013 Pp. 294-S295. %u2013 https://doi.org/10.1192/j.eurpsy.2024.61315. %u041e%u0432%u0447%u0438%u043d%u043d%u0438%u043a%u043e%u0432 %u0410.%u0410., %u0421%u0443%u043b%u0442%u0430%u043d%u043e%u0432%u0430 %u0410.%u041d., %u0421%u0442%u0430%u043d%u043a%u0435%u0432%u0438%u0447 %u0410.%u0421., %u041d%u0430%u0440%u043e%u0432 %u041c.%u042e., %u0427%u0443%u0442 %u0423.%u042e., %u0418%u043e%u0430%u043d%u0438%u0434%u0438 %u0414.%u041a., %u041b%u0443%u0433%u043e%u0432%u0435%u043d%u043a%u043e %u0412.%u0410. %u041e%u0441%u043e%u0431%u0435%u043d%u043d%u043e%u0441%u0442%u0438 %u0430%u0434%u0434%u0438%u043a%u0442%u0438%u0432%u043d%u044b%u0445 %u0440%u0430%u0441%u0441%u0442%u0440%u043e%u0439%u0441%u0442%u0432 %u0438 %u0430%u0444%u0444%u0435%u043a%u0442%u0438%u0432%u043d%u043e%u0439 %u0441%u0438%u043c%u043f%u0442%u043e%u043c%u0430%u0442%u0438%u043a%u0438 %u043f%u0440%u0438 %u0448%u0438%u0437%u043e%u0444%u0440%u0435%u043d%u0438%u0438 // %u0421%u0438%u0431%u0438%u0440%u0441%u043a%u0438%u0439 %u0432%u0435%u0441%u0442%u043d%u0438%u043a %u043f%u0441%u0438%u0445%u0438%u0430%u0442%u0440%u0438%u0438 %u0438 %u043d%u0430%u0440%u043a%u043e%u043b%u043e%u0433%u0438%u0438. %u2013 2021. %u2013 Vol. 2 (111). %u2013 Pp. 23%u201331. %u2013 https://doi.org/10.26617/1810-3111-2021-2(111)-23-3115. Ovchinnikov A.A., Sultanova A.N., Stankevich A.S., Narov M.Ju., Chut U.Ju., Ioanidi D.K., Lugovenko V.A. Osobennosti addiktivnyh rasstrojstv i affektivnoj simptomatiki pri shizofrenii // Sibirskij vestnik psihiatrii i narkologii. %u2013 2021. %u2013 Vol. 2 (111). %u2013 Pp. 23%u201331. %u2013 https://doi.org/10.26617/1810-3111-2021-2(111)-23-3116. Busner J., Targum S.D. The clinical global impressions scale: applying a research tool in clinical practice // Psychiatry (Edgmont). %u2013 2007. %u2013 Vol. 4 (7). %u2013 Pp. 28%u201337. 16. Busner J., Targum S.D. The clinical global impressions scale: applying a research tool in clinical practice // Psychiatry (Edgmont). %u2013 2007. %u2013 Vol. 4 (7). %u2013 Pp. 28%u201337. 17. Endicott J., Spitzer R.L., Fleiss J.L., Cohen J. The global assessment scale: A procedure for measuring overall severity of psychiatric disturbance // Arch Gen Psychiatry. %u2013 1976. %u2013 No. 33. %u2013 Pp. 766%u2013771.17. Endicott J., Spitzer R.L., Fleiss J.L., Cohen J. The global assessment scale: A procedure for measuring overall severity of psychiatric disturbance // Arch Gen Psychiatry. %u2013 1976. %u2013 No. 33. %u2013 Pp. 766%u2013771.18. %u041c%u043e%u0441%u043e%u043b%u043e%u0432 %u0421.%u041d. %u0428%u043a%u0430%u043b%u044b %u043f%u0441%u0438%u0445%u043e%u043c%u0435%u0442%u0440%u0438%u0447%u0435%u0441%u043a%u043e%u0439 %u043e%u0446%u0435%u043d%u043a%u0438 %u0441%u0438%u043c%u043f%u0442%u043e%u043c%u0430%u0442%u0438%u043a%u0438 %u0448%u0438%u0437%u043e%u0444%u0440%u0435%u043d%u0438%u0438 %u0438 %u043a%u043e%u043d%u0446%u0435%u043f%u0446%u0438%u044f %u043f%u043e%u0437%u0438%u0442%u0438%u0432%u043d%u044b%u0445 %u0438 %u043d%u0435%u0433%u0430%u0442%u0438%u0432%u043d%u044b%u0445 %u0440%u0430%u0441%u0441%u0442%u0440%u043e%u0439%u0441%u0442%u0432. %u2013 %u041c.: %u041d%u043e%u0432%u044b%u0439 %u0446%u0432%u0435%u0442, 2001. %u2013 239 c.18. Mosolov S.N. Shkaly psihometricheskoj ocenki simptomatiki shizofrenii i koncepcija pozitivnyh i negativnyh rasstrojstv. %u2013 M.: Novyj cvet, 2001. %u2013 239 c.19. %u0428%u0438%u0437%u043e%u0444%u0440%u0435%u043d%u0438%u044f. %u041a%u043b%u0438%u043d%u0438%u0447%u0435%u0441%u043a%u0438%u0435 %u0440%u0435%u043a%u043e%u043c%u0435%u043d%u0434%u0430%u0446%u0438%u0438. %u0412%u0437%u0440%u043e%u0441%u043b%u044b%u0435. %u042d%u043b%u0435%u043a%u0442%u0440%u043e%u043d%u043d%u043e%u0435 %u0438%u0437%u0434%u0430%u043d%u0438%u0435. %u2013 %u041c%u0438%u043d%u0437%u0434%u0440%u0430%u0432 %u0420%u0424. %u2013 %u041c., 2021. %u2013 134 %u0441. %u2013 URL: https://cr.minzdrav.gov.ru/recomend/451_2 (accessed July 7, 2024).19. Shizofrenija. Klinicheskie rekomendacii. Vzroslye. Jelektronnoe izdanie. %u2013 Minzdrav RF. %u2013 M., 2021. %u2013 134 s. %u2013 URL: https://cr.minzdrav.gov.ru/recomend/451_2 (accessed July 7, 2024).20. %u041c%u043e%u0441%u043e%u043b%u043e%u0432 %u0421.%u041d., %u0426%u0443%u043a%u0430%u0440%u0437%u0438 %u042d.%u042d., %u0410%u043b%u0444%u0438%u043c%u043e%u0432 %u041f.%u0412. %u0410%u043b%u0433%u043e%u0440%u0438%u0442%u043c%u044b %u0431%u0438%u043e%u043b%u043e%u0433%u0438%u0447%u0435%u0441%u043a%u043e%u0439 %u0442%u0435%u0440%u0430%u043f%u0438%u0438 %u0448%u0438%u0437%u043e%u0444%u0440%u0435%u043d%u0438%u0438 // %u0421%u043e%u0432%u0440%u0435%u043c%u0435%u043d%u043d%u0430%u044f %u0442%u0435%u0440%u0430%u043f%u0438%u044f %u043f%u0441%u0438%u0445%u0438%u0447%u0435%u0441%u043a%u0438%u0445 %u0440%u0430%u0441%u0441%u0442%u0440%u043e%u0439%u0441%u0442%u0432. %u2013 2014. %u2013 %u2116 1. %u2013 %u0421. 27%u201336.20. Mosolov S.N., Cukarzi Je.Je., Alfimov P.V. Algoritmy biologicheskoj terapii shizofrenii // Sovremennaa Terapia Psihiceskih Rasstrojstv. %u2013 2014. %u2013 %u2116 1. %u2013 S. 27%u201336.21. Mosolov S.N., Yaltonskaya P.A. Primary and Secondary Negative Symptoms in Schizophrenia // Front Psychiatry. %u2013 2022. %u2013 No. 12. %u2013 Art. 766692. %u2013 https://doi.org/10.3389/fpsyt.2021.76669221. Mosolov S.N., Yaltonskaya P.A. Primary and Secondary Negative Symptoms in Schizophrenia // Front Psychiatry. %u2013 2022. %u2013 No. 12. %u2013 Art. 766692. %u2013 https://doi.org/10.3389/fpsyt.2021.766692